NHS Guidance on Self-Monitoring During GLP-1 Treatment The NHS, guided by NICE recommendations, emphasises structured, individualised self-monitoring as part of comprehensive diabetes care
3 The American Academy of Pediatrics recommends considering pharmacotherapy for adolescents with obesity, but the introduction of potent medications (eg, GLP-1 receptor agonists) presents a host of complex psychosocial and financial questions that extend beyond clinical efficacy
Some substances, including methamphetamine, currently have no approved medications for treatment
PMID: 27092049 DOI: 10.3389/fnins.2016.00148 Raiteri M, Levi G (1986): A reinterpretation of tyramine sympathomimetic effect and tachyphylaxis
It increases heart rate and blood pressure whilst suppressing appetite, making it suitable only for short-term usetypically 12 weeks or less